2026 IAP Fall CME Meeting
IAP MEMBERS MUST LOG IN FOR REGISTRATION DISCOUNT
IAP 2026 Fall CME Meeting (virtual)Meeting Points
Register Now Faculty Biosketches Agenda CME Information 2026_Fall_CME_Meeting_Brochure.pdf
 John Oyelakin-Ogunbileje, PhD Assistant Professor of Clinical Pathology & Laboratory Medicine Medical Director at Simon Cancer Center Laboratory at University Hospital, Indianapolis, IN Medical Director, Sweat Chloride Testing at Riley Hospital for Children, Indianapolis, IN |
Rohit Gulati, MBBS Associate Professor of Clinical Pathology & Laboratory Medicine Director, Hematopathology Fellowship Program Carrie L. Phillips, MD Bicentennial Professor of Pathology & Laboratory Medicine Professor of Medicine Vice Chair Faculty and Staff Development Hannah Hyaduck, MD Chief Resident, IU Pathology Residency Program |
Lin Wang, MD, PhD Assistant Research Professor of Pathology & Laboratory Medicine Indiana University School of Medicine |
Breaking Diagnostic Silos in Multiple Myeloma (Part 1) Objectives: At the end of this activity, participants should be able to:
Multiple myeloma is a genetically heterogeneous plasma cell neoplasm with manifestations across bone, kidney, and the hematopoietic system. Diagnosis depends on tests owned by different laboratory specialties — serum free light chains, protein electrophoresis, and mass spectrometry–based monoclonal protein testing in clinical chemistry; marrow morphology, flow cytometry, and clonality in hematopathology; and biopsy interpretation in renal pathology. In practice these are run and reported as linear, compartmentalized workflows. Discordant results are not reconciled across specialties, so diagnostic delays and misinterpretations persist, and minimal residual disease (MRD) assessment is inconsistently integrated with hematologic and renal findings. | Breaking Diagnostic Silos in Multiple Myeloma (Part 2) Objectives: At the end of this activity participants should be able to:
| Molecular Genetic Pathology in Multiple Myeloma Objectives: At the end of this activity participants should be able to:
What's it about? Molecular testing also requires coordinated specimen preparation and interpretation. Multiple myeloma is a genetically heterogeneous plasma-cell neoplasm and molecular and cytogenetic testing is important for diagnosis, classification, and risk assessment. This presentation will provide information for participants to understand current testing methods, the additional information provided by NGS, and the importance of plasma-cell enrichment for accurate testing. This presentation will review these topics and share the Indiana University experience with NGS validation in multiple myeloma. |
Morning Session 9:00 am Breaking Diagnostic Silos in Multiple Myeloma (Part 1) 10:00 am Breaking Diagnostic Silos in Multiple Myeloma (Part 2) 11:00 am Break 11:15 am Molecular Testing in Multiple Myeloma: Current and Future Perspectives 12:15 pm Follow-up Q and A 12:30 pm End of Program |
CME information Joint Providership Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of American Pathologists and the Indiana Association of Pathologists.. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Statement The College of American Pathologists designates this live (or internet live) educational activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Disclaimer The content of this accredited CE (CME) activity does not necessarily reflect the view or policies of the College of American Pathologists. Disclosure Information Below you will find the financial disclosure relationships for anyone who was able to affect the content of this educational activity. The following speakers/planners have no financial relationships to disclose: Andrew Tharp, MD Sheila Segura, MD Carrie Phillips, MD Norma Erickson, MA Lin Wang, MD, PhD Rohit Gulati, MBBS Hannah Hyaduck, MD No speakers/planners disclosed financial relationships. The following In-Kind Support has been received for this activity: None The following Commercial Support has been received for this activity: None |
Faculty Bios
John Oyelakin-Ogunbileje, PhD
Assistant Professor of Clinical Pathology & Laboratory Medicine
Medical Director at Simon Cancer Center Laboratory at University Hospital, Indianapolis, IN
Medical Director, Sweat Chloride Testing at Riley Hospital for Children, Indianapolis, IN
Rohit Gulati, MD
Director, Hematopathology
Associate Professor of Clinical Pathology & Laboratory Medicine
Director, Hematopathology Fellowship Program
Carrie L. Phillips, MD
Bicentennial Professor of Pathology & Laboratory Medicine
Professor of Medicine
Vice Chair Faculty and Staff Development
Lin Wang, MD, PhD
Dr. Lin Wang is an Assistant Research Professor in the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine. She received her MD in Pediatrics from Inner Mongolia Medical College and her PhD in Cell Biology from Peking Union Medical College. She completed her postdoctoral fellowship at the Herman B Wells Center for Pediatric Research at Indiana University School of Medicine before joining the Department of Pathology and Laboratory Medicine. Dr. Wang’s research focuses on assay development, clinical validation, and the integration of emerging technologies into routine clinical diagnostics. Her work bridges innovative laboratory methods and technologies with clinical practice to address the evolving needs of clinical laboratories and, ultimately, improve patient care.